Events: An International Webinar on “CRISPR Technology: Expanding the Public Health Impacts of Gene Editing” organized by Genetic Engineering and Biotechnology News

Date: October 12, 2023 (Thursday)

Time: 10:00 am PT, 1:00 pm RT, 19:00 CET

Event Description:

In this live webinar, Dr. Fyodor Urnov, a trailblazer in the field of human genome editing, will address the pressing challenge currently faced by the clinical genome editing community. This challenge pertains to the crucial task of broadening the public health impact of CRISPR-Cas technology. A significant obstacle encountered in all genetic therapies, whether related to finances, logistics, or regulatory requirements, is the need to establish a scalable, clinic-grade manufacturing process for experimental therapeutics. The existing costs, timelines, and prerequisites within this domain render the vast majority of genetic diseases practically insurmountable.

Dr. Urnov will delve into the distinctive characteristics of CRISPR-Cas as a versatile platform technology. This technology holds the potential to harness nonclinical and manufacturing knowledge from one disease application and apply it to others, potentially eliminating the need for redundant, expensive, and time-consuming nonclinical studies. The use of non-viral CRISPR-Cas delivery, such as Cas9 ribonucleoprotein (RNP), serves as a compelling case study. It demonstrates how essential elements of the manufacturing framework can be shared across different disease contexts.

During the webinar, Dr. Urnov will evaluate the most recent advancements in clinical genome editing and explore how further progress can be facilitated through innovative collaborations between academia and industry. These partnerships aim to develop manufacturing innovations within the realm of “CRISPR-Cas as a therapeutic platform” and bring them into practical, real-world application.

Guests Speakers:

Registration: FREE

Registration Deadline: Not Mentioned